Research Research groups Molecular therapies for otogenetic disorders

About

We focus on the genetic diagnosis, understanding the underlying pathogenic mechanisms of disease, and the development of genetic treatments for conditions with late-onset, progressive hearing and vision loss (DFNA9/21/22; USH2a/2c/1d/1f).


Research group leader

dr. Erwin van Wyk

contact form

Aims

See our most important goals.

read more

Aims

  1. Developing RNA therapies for otogenetic disorders
  2. Developing personalized ‘n-of-1’ treatments for ultra-rare variants
  3. Improving delivery of therapeutic molecules to the inner ear
  4. Generation and characterization of innovative models for otogenetic disorders
  5. Unraveling regeneration pathways in zebrafish



Publications

See some of our most important scientific articles.

read more

Publications

See the publication list of the research group leader on Web of Science.



Profile page

See the group leader's profile.

see page

Research programs

Programs that are connected to this research group.